From a different perspective, our strategy involving unspecific polyclonal stimuli prior to infection allows us to expand on the body of evidence supporting that PD-1 expression increases as IL-2 and IFN-gamma production decreases in severe COVID-19. This evidence concerns the gene PDCD1 and COVID-19.